Dr Michael Schachter is Senior Lecturer in Clinical Pharmacology. He is responsible for the organisation and delivery of the clinical pharmacology course, with a recently increased emphasis on practical prescribing, and he is also the senior examiner for this subject. He is a module co-leader and project organiser for the cardiovascular BSc course, and teaches on several other BSc courses and in years 1, 2 and 3. His largest single role however is as Faculty Senior Tutor, with a welfare and academic role encompassing the clinical years of the MB course but overall for the whole Medical School. He is therefore very much involved in School administration and organisation. He is also a postgraduate tutor for the National Heart and Lung Institute. Dr Schachter won an Imperial College Teaching Fellowship and Teaching Excellence Award in 2004.He is also an honorary consultant physician at Imperial Healthcare NHS Trust but has ceased active participation in clinical work. He is a member of the Trust’s New Drugs Panel and Drug and Therapeutics Committee, of which he is vice-chair.
He qualified at University College London and also took an intercalated BSc in biochemistry. After his pre-registration year he worked at the Royal Marsden Hospital and then on a registrar rotation at King’s College Hospital, where he undertook research in the clinical pharmacology of Parkinson’s disease and narcolepsy at the University Department of Neurology. From then he moved to Oxford, and at the Department of Clinical Pharmacology there worked on mostly laboratory-based projects in cardiovascular and psycho-pharmacology. On moving to St Marys’ Hospital Medical School he worked again mostly on laboratory-based projects relating to receptor pharmacology in a variety of tissues and clinical contexts. Later he became involved in research on prescribing errors and this remains a continuing interest. His increased involvement in medical education dates from the foundation of the joint undergraduate school at Imperial in 1997.
Dr Schachter reviews papers and articles for many journals and also reviews grant applications. He contributes frequently to books and reviews, undeterred by ignorance. He is editor in chief of Therapeutic Advances in Chronic Disease and executive editor of the Journal of the Renin Angiotensin Aldosterone System. At times he is quite busy, but usually answers emails quickly.
Schachter M, 2014, Novel oral anticoagulants: too good to be true?, Postgraduate Medical Journal, Vol:90, ISSN:0032-5473, Pages:485-485
Schachter M, 2012, Professional judgment is key in treating hypertension., Bmj, Vol:344
Schachter M, 2012, MANAGING HYPERTENSION Professional judgment is key in treating hypertension, British Medical Journal, Vol:344, ISSN:0959-535X
Schachter M, 2012, Instead of jumping up and down we must propose alternatives., Bmj, Vol:344
Poulter NR, Prabhakaran D, Caulfield M, 2015, Hypertension, ELSEVIER SCIENCE INC